As the 2030 Sustainable Development Goals (SDGs) deadline looms, African governments are now doubling down on their commitments to end preventable deaths of children under five as envisioned by the ...

If successful, M72 might be the first new TB vaccine in more than a century to meet the WHO's target product profile, ...

From agricultural lands to technology startups, African women are not only building, but they are endlessly reinventing the economy. Even when women are said to be the backbone of the family and the ...

A healthcare-focused panel discussion at this year’s Sapics Conference in Cape Town spotlighted Africa’s emergence as a ...

The initiative was first piloted across five countries, namely, Côte d’Ivoire, Ghana, Kenya, Senegal and Zimbabwe ...

A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 global participants enrolled by GlaxoSmithKline (GSK). Pharmaceutical giant ...